Genomics researchers
Prioritize candidate variants and inspect proposed molecular effects before committing to experiments.
Independent tool overview
AlphaGenome Atlas is a research portal and precomputed dataset for exploring the predicted molecular effects of all 9 billion possible single-letter changes in the human genome. Its AlphaGenome Variant Impact score connects coding and noncoding changes to possible biological mechanisms; it is evidence for prioritizing investigation, not a clinical diagnosis.
Visit the official AlphaGenome Atlas site ↗
Overview
The Atlas turns a difficult one-variant-at-a-time modeling problem into a searchable map. Google DeepMind precomputed AlphaGenome predictions for every possible single-nucleotide variant, producing a dataset of about one petabyte. Researchers can start with a specific location or a list of candidates, inspect predicted effects on gene regulation, and compare the resulting scores. The public website is intended to make this possible without writing code, while the AlphaGenome API serves computational workflows.
Its AlphaGenome Variant Impact (AVI) score condenses evidence from AlphaGenome and AlphaMissense into one prioritization signal across protein-coding and noncoding regions. The linked feature attributions matter as much as the headline number: they indicate which predicted mechanisms, such as RNA splicing or gene expression, drove a high score. The Atlas also links a catalogue of more than 2,500 DNA sequence motifs. This is useful when a team needs a plausible biological hypothesis to test, rather than merely a ranked list.
The most persuasive examples are research demonstrations, not blanket claims of clinical accuracy. Google describes a rare-disease case where an incorrect splice-site prediction helped support resolution of an unsolved case, and a complex-trait study using data from more than 54,000 UK Biobank participants. These examples show a route from model prediction to further analysis, but each condition, population, cell type, and variant still requires independent evidence. Model coverage cannot substitute for functional experiments, segregation evidence, or professional interpretation.
Use cases
The strongest fit depends on the job you need the product to complete, not the size of its feature list.
Prioritize candidate variants and inspect proposed molecular effects before committing to experiments.
Use coding and noncoding predictions as supporting evidence alongside clinical and genetic data.
Incorporate precomputed variant evidence into larger discovery pipelines.
Capabilities
Explore molecular-effect predictions without running the base model separately for every candidate.
Compare coding and noncoding candidates through the AVI prioritization signal.
Trace high scores back to predicted splicing, expression, chromatin, protein or other contributing features.
Use the no-code Atlas interface or adjacent AlphaGenome API and skills where those fit the research workflow.
Process
Step 1
Begin with a variant or a research list and locate its Atlas record.
Step 2
Read the AVI score together with feature attributions and tissue or cell-type context.
Step 3
Check primary literature and experimental or clinical evidence before drawing consequential conclusions.
Cost
Google states that the Atlas website is free for noncommercial research. Commercial Atlas access was announced as coming to Google Cloud; no public commercial Atlas price was verified.
Free for noncommercial use
Browser-based research access to the precomputed Atlas.
Pricing not published
Google says a commercial Cloud route is forthcoming.
Pricing checked . Check current pricing at the source ↗
Assessment
Compare
The right alternative depends on the specific output, workflow, controls and budget your project requires.
Science
Explore a research assistant for biomedical literature analysis rather than genome-wide variant scoring.
Explore SciSpace BioMed Agent →Healthcare
Consider a medical-domain open model for separate text or multimodal development work.
Explore MedGemma →Questions
No. It predicts molecular effects and supports research prioritization. Clinical interpretation requires independent evidence and qualified review.
The AlphaGenome Variant Impact score combines predicted evidence for coding and noncoding variants into a prioritization signal with linked feature attributions.
Yes. Google describes a free noncommercial browser portal, with related API options for computational work.
Bottom line
AlphaGenome Atlas is compelling when the bottleneck is deciding which of many variants deserves closer study. The precomputed scale and interpretable AVI features offer more than a simple pathogenicity rank, particularly for noncoding hypotheses. Its value depends on careful validation: treat every result as a model prediction, match it to the relevant tissue and phenotype, and document the external evidence that supports any downstream claim.
Visit AlphaGenome Atlas website ↗
Get access to all our AI courses, hundreds of real-world AI use cases, live expert-led workshops, an exclusive network of AI early adopters, and more.
Get unlimited access to all of our current & upcoming industry-specific AI courses for the duration of your subscription.
To keep up with the rapid pace of AI, our team publishes AI implementation guides daily. Our library contains 300+ practical use cases to automate real-world work.
Join weekly, live, interactive sessions with industry leaders who are at the forefront of AI for hands-on implementation guidance and exclusive insights.
Network with an exclusive community of AI-first professionals who are working smarter with AI. Learn how early adopters are using AI in their work and businesses.